Research and Markets: EU Biosimilars Database - Details of All Marketed and Pipeline Biosimilars

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hxk6pb/eu_biosimilars) has announced the addition of the "EU Biosimilars Database" report to their offering.

Excel deliverable containing data on marketed and pipeline biosimilars in the EU

Details of all marketed and pipeline biosimilars in the EU. View by product, selecting a molecule name; assess a biosimilar company's pipeline; or view the full pipeline and filter on all 11 labels.

Scope

- Pipeline: details of the full pipeline of products, select all or filter by country and sort by a variety of criteria

- Product: select an individual product and view details of all associated biosimilars in development in the EU

- Company: select either a biosimilar source company or a partner company to view details of all biosimilar products in its EU portfolio

Highlights

- Database of marketed and pipeline biosimilars in the EU, based on company-reported information and a variety of other sources.

Reasons to Purchase

- Identify which products are being targeted by biosimilars developers and which companies are active in the EU biosimilars market

- Analyze the pipeline of biosimilar products in development in the EU by therapy area, molecule type and company amongst other criteria

Key Topics Covered:

EU BIOSIMILARS DATABASE

- Access the database

- Features and benefits

APPENDIX

- Exchange rates

TABLES

- Table: Exchange rates, 2012

For more information visit http://www.researchandmarkets.com/research/hxk6pb/eu_biosimilars